Antihyperlipidaemic and Antioxidant Potential of Fermented Citrullus vulgaris Seeds (Thunb.) on Tyloxapol-induced Hyperlipidaemic Rats: A Comparison With Fluvastatin by Ayo-Lawal, Aderonke R. et al.
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/281191657
Antihyperlipidaemic and Antioxidant Potential of Fermented Citrullus
vulgaris Seeds (Thunb.) on Tyloxapol-induced Hyperlipidaemic Rats: A
Comparison With Fluvastatin
Article · June 2015
DOI: 10.5539/jfr.v4n4p110
CITATIONS
0
READS
63
3 authors, including:
Some of the authors of this publication are also working on these related projects:
Cytotoxic Studies of Certain Medicinal Plant View project
Novel cytotoxic compounds View project
Aderonke R Ayo-Lawal
National centre for Technology Management, Ile-Ife, Osun State
3 PUBLICATIONS   4 CITATIONS   
SEE PROFILE
R. Omolaja Osoniyi
Obafemi Awolowo University
24 PUBLICATIONS   261 CITATIONS   
SEE PROFILE
All content following this page was uploaded by R. Omolaja Osoniyi on 05 May 2017.
The user has requested enhancement of the downloaded file.
Journal of Food Research; Vol. 4, No. 4; 2015 
ISSN 1927-0887 E-ISSN 1927-0895 
Published by Canadian Center of Science and Education 
110 
 
Antihyperlipidaemic and Antioxidant Potential of Fermented Citrullus 
vulgaris Seeds (Thunb.) on Tyloxapol-induced Hyperlipidaemic Rats: 
A Comparison With Fluvastatin 
Aderonke R. Ayo-Lawal1,2, Omolaja Osoniyi2 & Akindele J. Famurewa1 
1 National Centre for Technology Management (NACETEM), Obafemi Awolowo University, Ile-Ife, Osun State, 
Nigeria 
2 Biochemistry Department, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria 
Correspondence: Aderonke R. Ayo-Lawal, NACETEM, PMB 012, Obafemi Awolowo University, Ile-Ife, Osun 
State, Nigeria. Tel: 234-70-345-846-45. E-mail: ronke_ode@yahoo.com 
 
Received: April 14, 2015   Accepted: May 29, 2015   Online Published: June 16, 2015 
doi:10.5539/jfr.v4n4p110       URL: http://dx.doi.org/10.5539/jfr.v4n4p110 
 
Abstract 
Globally fermented foods form an integral part of the staple diet of people. Fermented Citrullus vulgaris (FCV) 
(ogiri) seeds is a nutritious natural fermented condiment that features frequently in West African diets as a spice. 
This study investigated the antihyperlipidaemic potential of this condiment in tyloxapol-induced hyperlipidaemic 
rats with reference to that of fluvastatin, a standard antilipidaemic drug. The antioxidant potential of the 
condiment was also examined using different relevant in vitro assays. Albino rats were divided into six groups 
(n=5), based on the diet and treatment received. The groups were standard feed (control); FCV supplemented 
feed; standard feed with tyloxapol administered at the end of the experimental period (tyloxapol control); FCV 
supplemented feed and tyloxapol at the end of the experimental period; standard feed with fluvastatin sodium 
(40 mg/kg and 80 mg/kg body weight separately) followed by tyloxapol. The results revealed that administration 
of tyloxapol induced significant (p < 0.05) increase in total-cholesterol (TC), low density lipoprotein cholesterol 
(LDL-C) and triglyceride (TG). These lipid increases were significantly mitigated in groups initially pre-fed with 
supplemented FCV feed. Plasma TC decreased by 69.38% (p < 0.05); TG by 80.58% (p < 0.05); LDL-C by 
7.80% (p < 0.05) and high density lipoprotein cholesterol (HDL-C) levels increased by 78.61% (p < 0.05). FCV 
showed appreciable antioxidant activities in vitro in a dose dependent manner. Histomorphological examination 
of the liver suggested that the FCV possessed hepatoprotective potential. These results suggest that FCV 
consumption may be a possible dietary measure for the control of dyslipidaemia. 
Keywords: fermented Citrullus vulgaris, Ogiri, fluvastatin, HDL-C, hyperlipidaemia, LDL-C, total-cholesterol, 
triglyceride, tyloxapol 
1. Introduction 
Lipid profile disorders are among the most common metabolic diseases occurring in humans and are a risk index 
of coronary heart disease (Edem, 2002; O. B. Ajayi & D. D. Ajayi, 2009). High concentrations of low density 
lipoprotein (LDL) and lower concentrations of functional high density lipoprotein (HDL) are strongly associated 
with cardiovascular disease because it promotes atheroma development leading to atherosclerosis. Strong 
correlations have been shown to exist between increased plasma total cholesterol (TC), LDL-cholesterol and 
increased incidence of coronary heart disease (Edionwe & Kies, 2009; Kamisah et al., 2005; Lewington et al., 
2007). The ratios of TC/HDL-cholesterol, LDL-Cholesterol/HDL-cholesterol and atherogenic index are 
predictors of coronary risk (National cholesterol education program, 1994). Meanwhile, the changes in eating 
habits including high fat and low fiber diets increased also the risk of obesity and overweight. Risk of these 
diseases increases steadily with increasing the values of body mass index (BMI) or food efficiency ratio 
(FER).Although significant strides have been made in the understanding and management of lipid disorders 
using synthetic medicines, the disease and its related conditions are still increasing. Many unwanted side effects 
of long-term use of many of the hypolipidaemic drugs have been frequently reported and many are still 
reportedly expensive for a lot of people in the third world (Ngoc et al., 2008; Rosebaum et al., 2012; Grundy, 
2013; Sultan & Hynes, 2013), thus developments of novel approaches from food, herbs, etc to battle the world 
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epidemic of hyperlipidaemia still remain relevant (Damjana &Katalin, 2010). Efforts to develop effective and 
better hypolipidaemic drugs had led to the exploration of active substances in natural agents. Preparations from 
plants and plants products are frequently considered to be less toxic, less expensive and have fewer side-effects 
than synthetic drugs (Odetola et al., 2006).  
Fermented foods and beverages form major part of the human diet all across the globe. They are prepared by 
using indigenous knowledge on locally available raw materials from plant or animal sources. Micro-organisms 
transform these raw materials both biochemically and organoleptically into edible products that are culturally 
acceptable to the maker and consumer. Fermentation technologies play an important role in ensuring the food 
security of millions of people around the world, particularly the marginalized and vulnerable groups (Agriculture 
and Consumer Protection (ACP)).Good nutrition is one of the basic human rights which must be satisfied in 
order to have a healthy population that can promote development. It therefore becomes important to balance the 
relationship between food, nutrition and health (Akinyele & Oloruntoba, 2013). In recent years, functional foods 
including fermented foods have attracted much interest to prevent nutrition-related diseases such as 
hyperlipidemia and weight gain. Nutritional as well as health-promoting benefits of many of the fermented foods 
have been well documented (ACP; Steinkraus, 1995). It has been reported for instance, that the product of 
industrial fermentation of wheat germ, possesses unique cancer-fighting characteristics, as well as prevention of 
chemical carcinogenesis, and some autoimmune conditions (Boros, Nichelatti, & Shoenfeld, 2005).  
Ogiri is an oily paste produced generally from fermentation of oil-rich seeds. Ogiri-egusi is a food condiment 
prepared traditionally by uncontrolled solid state fermentation of melon seeds (Citrullus vulgaris) (Achi, 2005; 
Akinyele and Oloruntoba, 2013) and consumed within the West African countries (Odunfa, 1981; Achi, 2005). 
This study is aimed at investigating the lipid-lowering potential of fermented Citrullus vulgaris, a popular soup 
condiment in Africa with reference to the standard lipid-lowering drug - fluvastatin in rats. This is with a view to 
establishing its use as a possible alternative in therapeutic management of hyperlipidaemia and associated 
conditions. 
2. Materials and Methods  
2.1 Condiment Fermentation 
Ogiri was prepared in the traditional way using dried melon seeds. The shells (husks) were removed; they were 
sorted to remove grit, dirt and decomposing seeds; and thereafter rinsed with warm water (35 °C) twice. The 
seeds were boiled for about one hour with ten times its volume of water. The boiled water was then drained and 
replaced by cold water and boiled again for about 6 hours to complete softness. At this stage, the transparent 
inner seed coats (tegmen) were easily removed. The pulpy melon seeds were then wrapped in Thaumatococcus 
daniellii leaves in different packets and cooked again for about 2-3 hours. Water and oil drained off from the 
wrapped pulp. The packets were placed in earthenware pots and covered with Thaumatococcus daniellii leaves. 
This provided low oxygen tension. The seeds were left to ferment for 5 days. The fermented product was then 
ground with stone mortar and pestle to almost a smooth paste. The fermented mash was ogiri. 
2.2 Preparation of Ogiri-Supplemented Feed (OSF) 
Feeds supplemented with ogiri was prepared by thoroughly mixing weighed condiment and standard rodent feed 
in a ratio 1:4 respectively to give a twenty percent (20%) (w/w) supplemented feed. The feed was pelletized by 
adding few drops of water, and passed through a roller to cake; and thereafter placed in the oven set at about 
40oC for drying and caking. Feeds were prepared prior to usage for stability and to avoid storage for a long time. 
2.3 Chemicals 
Tyloxapol (Triton WR 1339) was obtained from Sigma Chemical Company, St. Louis Missouri, USA. 
Diagnostic kits for cholesterol, triglycerides and high-density lipoprotein (HDL) deternimations were purchased 
from Randox Laboratories, Antrim, United Kingdom. Fluvastatin sodium and all other reagents were of 
analytical grade and the purest quality available. 
2.4 Experimental Animals & Feed Composition 
Animal house with standard animal cages and maintained at 26-29 °C with a 12 hours light–dark cycle was used 
for the experiment. Rats weighing between 75 and 110 g (bothsexes), were acclimatized for 2 weeks before the 
commencement of the experiment. Animals were fed on standard laboratory chow purchased from Bendel Feeds 
and Flour Mills limited, Benin Road, Ewu, (EdoState, Nigeria) and contained 14.5% crudeprotein, 4.8% crude 
fat, 7.2% crude fiber, 8% crude ash, 0.62% Phosphate, 0.33% available Phosphorus, 0.6% lysine, 0.29% 
Methionine, 0.52% Methionine + Cystine, (8,000 I.U Vitamin A, 2,400 I.U Vitamin D3, 15 mg Vitamin E, 4 mg 
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Vitamin B2, 50 mg Vitamin C, 30 mg Manganeze, 30 mg Zinc, 0.15% Sodium) per Kg feed. After 
acclamitization, rats were randomly sorted into six groups of five animals each.  
2.5 Experimental Animal Groupings 
Group A served as the control group and received standard feed (no treatment). Group B received 
ogiri-supplemented feed (OSF) only; group C was fed standard feed, and tyloxapol administered after the 
experimental period (tyloxapol control), D received OSF, and tyloxapol administered after the experimental 
period; groups E and F received standard feed, tyloxapol administered after the experimental period and 
fluvastatin sodium 40 mg/kg and 80 mg/kg body weight respectively. Tyloxapol was administered to groups C, D, 
E and F as described above at the end of the six weeks experimental period. Weekly weight change was 
monitored in rats. 
2.6 Administration of Tyloxapol 
At the end of the six weeks experimental period, animals were deprived of food for 24-hours, after which 
hyperlipidaemia was induced by a single intraperitoneal injection of tyloxapol 250 mg/kg body weight of rats 
(Ansarullah et al., 2009) to groups C, D, E and F mentioned above. 
2.7 Administration of Fluvastatin Sodium 
Two doses of the drug (40 mg and 80 mg per body weights of rats) were administered 12-hours after injection of 
tyloxapol to groups E and F orally by intubation. Rats were left for another 12 hrs before sacrifice. 
2.8 Sample Collection 
48-hrs after the end of feed regimen (i.e. 12-hrs after fluvastatin administration), rats in all the groups were 
sacrificed by cervical dislocation. Blood samples were withdrawn from fasted rats by cardiac puncture using 
needles and syringes into heparinised bottles. Blood samples were centrifuged with a bench centrifuge at 3000 
revolution per minute for 15minutes. Plasma samples used for the assays were separated. Rats’ livers were also 
removed.  
2.9 Preparation of Liver Homogenates 
Liver samples were washed with normal saline and blotted dry with paper towels. 1g each was homogenized in 
10 ml of 0.25 M sucrose solution to give 10% (w/v) homogenates. 
2.10 Lipid Profile Estimation 
Plasma triglycerides (TG) and total cholesterol (TC) levels were assayed using commercial kits (Randox 
Laboratories). The high density lipoprotein-cholesterol (HDL) was measured using the enzymatic colorimetric 
method. After centrifugation at 3000 g for 10 minutes at 25 °C, the clear supernatant contained the HDL fraction, 
which was assayed for cholesterol using a Randox kit. Low density lipoprotein–cholesterol (LDL-C) was 
calculated using the formula of Friedwald et al. (Friedwald, Levy & Fredicksm, 1972). 
2.11 In vitro Antioxidant Assays 
In order to ascertain the antioxidant potentials of the condiment, various standard antioxidants assays are used. 
Standard in vitro methods used include: 2,2-Diphenyl-1- picrylhydrazyl (DPPH) free radical scavenging assay 
(Blois, 1958), nitric oxide radical inhibition activity (Marcocci, Packer, & Droy-Lefaix, 1994), anti lipid 
peroxidation assay (Nabasree & Bratati, 2002), ascorbic acid equivalent (Benzie& Strain, 1999) methods. All the 
assays were carried out in triplicate and average values calculated. 
2.12 Histomorphological Investigation 
Histomorphological investigation was performed at the Department of Anatomy and Cell Biology, Obafemi 
Awolowo University. The procedure involved fixing the liver tissue in 10% formal saline and processing via 
paraffin wax embedding and staining with Hematoxylin and Eosin method of Drury and Wallington (Drury & 
Wallington, 1980).  
2.13 Statistical Analysis 
Statistical evaluation of the data was done using Graph Pad Prism version 5.0 for Windows, Graph Pad Software, 
San Diego California USA (Ansarullah et al., 2009). The difference between groups was analyzed by one - way 
analysis of variance (ANOVA) followed by Bonferroni’s Multiple Comparison Test with 5% level of 
significance (P < 0.05) considered significant. Values are expressed as Mean ± SEM (Standard Error of Mean).  
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3. Results 
3.1 Average Weight Change 
A different growth pattern was observed between the group of rats fed standard rodent feed and OSF. Average 
weight gained throughout the experimental period are as depicted in Figure 1. Obviously tyloxapol and 
fluvastatin had no impact on the animal weight being experimental end points treatments. From the figure, it 
follows that continuous feeding of rats with the condiment for six weeks resulted in improved growth evidenced 
by moderate weight gain. 
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Figure 1. Graph of average mean weight of rats (A-F are as described in section 2.5) 
(A: Standard feed (control); B: OSF only; C: Standard feed + Tyloxapol; D: OSF + Tyl; E: Standard feed + 
Tyloxapol + Fluvastatin (40 mg/body weight); F: Standard feed + Tyloxapol + Fluvastatin (80 mg/ body weight) 
 
3.2 Plasma Lipid Profile 
The plasma lipid profile analyses revealed a significant increase (P < 0.05) in TC, LDL-C (67.27%) and TG in 
tyloxapol-treated rats (Group C). Ogiri-supplemented feed significantly (P < 0.05) mitigated the increment when 
+ and * are compared in figure 2. The condiment induced statistically significant (P < 0.05) hypocholesterolemic 
effect compared with fluvastatin at both concentrations used in this study. OSF mitigated increased TG due to 
tyloxapol administration when + and * are compared in Figure 3. 80mg/kg body weight fluvastatin showed a 
competitive hypotriglyceridaemic activity with the condiment (Figure 3), as both are statistically insignificant at 
P < 0.05. As shown in figure 4, OSF significantly (P < 0.01) mitigated increased LDL-C due to tyloxapol 
administration when + and * are compared. This activity was much higher than what was observed at both 
concentrations of fluvastatin. FCV yielded a statistically significant reduction (P < 0.05) in LDL-C. Tyloxapol 
induced a significant (P < 0.05) reduction in plasma HDL-C while OSF significantly (P < 0.01) induced 
increased HDL-C in pre-fed rats (Figure 5).  
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pre-fed rats gave statistically significant (P < 0.05) increase in HDL-C values with tyloxapol administered. 
Fluvastatin at both concentrations gave higher values compared with OSF. 
 
Table 1. Values of liver homogenates’ lipid profile estimation 
Treatment groups HDL-Cholesterol (mmol/l) 
Triglyceride 
(mmol/l) 
Total Cholesterol 
(mmol/l) 
Standard feed only (control), 
Ogiri-supplemented feed 
Standard feed+ tyloxapol 
0.332 ± 0.02 
0.340 ± 0.02 
0.265 ± 0.03 
1.628 ± 0.13 
1.751 ± 0.08 
2.253 ± 0.09 
1.237 ± 0.14 
0.937 ± 0.02 
2.328 ± 0.07 
Ogiri-supplemented feed +tyloxapol 
Standard feed+tyloxapol+fluvastatin 
(40 mg) 
0.598 ± 0.06 
0.722 ± 0.02 
1.722 ± 0.09 
1.247 ± 0.07 
1.800 ± 1.04 
1.183 ± 0.05 
Standard feed+tyloxapol+fluvastatin 
(80 mg) 0.914 ± 0.11 1.745 ± 0.04 1.658 ± 0.07 
Values are expressed as Mean±SEM of duplicate readings. P < 0.05 was considered significant.  
 
3.3 Antioxidant Activities 
The condiment showed considerable antioxidant potentials (Table 2) in comparison with the reference 
antioxidant agents used.  Activities were concentration dependent, i.e., the higher the sample concentration, the 
greater the antioxidant activity. 
 
Table 2. Antioxidant assay results 
DPPH Nitric oxide Anti-lipid peroxidation Ascorbic acid equivalent 
Conc. 
(mg/ml) 
% 
inhibition 
Conc.   
(mg/ml) 
%  
inhibition 
Conc.   
(mg/ml) % inhibition
Conc.    
(mg/ml) 
% inhibition 
(µgVitCeqv/g)
25.00 52.32±2.17 100.00 42.39±1.05 100.00 18.94±0.02 100.00 0.64 
12.50 29.54±2.01 50.00 37.96±0.84 50.00 10.57±3.16 50.00 0.95 
6.25 23.78±3.16 25.00 36.09±1.07 25.00 4.22±0.20 25.00 0.81 
3.12 1.48 ±0.18 12.50 - 12.50  12.50  
IC50 23.05 35.26 17.41 35.26    
Values are mean ± SEM of triplicate readings. Conc.- (concentration); µg VitCeqv/g- (unit of standard Vitamin C 
used for the assay. i.e. microgram vitamin C equivalent per gram); mg/ml- milligram per milliliter. 
 
3.4 Liver Sections Examined 
Histomicrographs examination revealed necrosed hepatocytes with poorly defined sinusoids in between the 
plates in the liver section of group C rats. However, in the FCV pre-treated rats, the liver sections appeared 
normal. Fluvastatin treated groups also showed nearly normal liver sections. Group E rat hepatocytes appeared 
normal with visible portal area. Hepatocytes of group F liver section also appeared normal. The hepatocytes are 
arranged in plates around the central vein with sinusoids in between the plates. The architecture of the liver of 
the condiment supplemented groups and standard group rats appear normal. The hepatocytes are arranged in 
plates around the central vein with sinusoids in between the plates (pictures not presented here).  
4. Discussion 
Fermented foods have been established to possess improved nutritional content (Odunfa, 1981; Omafuvbe et al., 
2004; Ognatan et al., 2011). Ogbonnaya et al., (Ogbonnaya, Orhevba, & Babatunde 2010), reported an increase 
in lipids, crude protein and certain minerals content due to fermentation in Parkia biglobosa seeds, a condiment 
used in a similar way to FCV. FCV is undoubtedly enriched with nutrients and hence triggered improved growth 
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in fed animals (Figure 1). Gadaga et al., (Gadaga, Nyanga, & Mutukumira 2004), also reported improvement of 
nutritional value and protection against bacterial pathogens in food as a result of fermentation.  
Tyloxapol - a chemical detergent was used to produce hyperlipidaemia in rats in this study. Its mechanism of 
action is known to accelerate the hepatic cholesterol synthesis in phase I (after 24-hour tyloxapol injection) 
(Ngoc et al., 2008). Tyloxapol in this study, in agreement with literature (Otway & Robinson, 1967; Abe et al., 
2007), induced significant increase in TC and TG, evident in the liver cell sections.  
This increase was abrogated as a result of pre-treatment of rats with the FCV condiment-composed diet. The 
condiment was effective in mitigating increased TC concentration, even better than at both concentration of the 
reference drug used in the study. Fermented Parkia biglobosa seeds showed similar observation when fed to 
tyloxapol-induced hyperlidaemic rats (Ayo-Lawal et al., 2014). The result of this study further showed that the 
condiment caused a significant (P < 0.05) increase in the plasma level of HDL-C, which is described as ‘good 
cholesterol’ (Agbedana, 1999). The combined effects of increased HDL-C and decreased LDL-C (bad 
cholesterol) resulted in an increased HDL-C/LDL-C ratio in the test animals. This suggests that supplementation 
of diet with the condiment might lead to a reduction in the risk of developing heart diseases, because a high 
HDL-C/LDL-C ratio has been shown to be beneficial and is indicative of a lower risk of coronary heart diseases 
(Castelli, 1984). Again, it has been repeatedly reported that the higher the level of LDL cholesterol, the greater 
the risk of atherosclerotic heart disease conversely the higher the level of HDL cholesterol the lower the risk of 
coronary heart disease (Grundy, 1986; LaRosa et al., 1990).  
There is a remarkable advantage in feeding with FCV over synthetic drug in this study. Treatment with 
fluvastatin sodium resulted in an HDL-C/LDL-C ratio that was lower than the value obtained from 
condiment-fed rats. Ngoc et al. (2009), also reported greater reduction in lipid profile from Abelmoschus 
esculentus extracts compared with the standard drug – simvastatin used in their study. The hypolipidaemic effect 
observed in plasma lipids and lipoproteins may also not be unconnected with the presence of the natural 
phytoconstituents in the seeds and others resulting from fermentation. From the results obtained for liver 
homogenates, this study established hepatoprotective effects of the condiment (Table 1). 
Histopathologically, it has been reported that administration of tyloxapol tends to damage the liver cells by 
reducing the activity of liver lipogenesis dehydrogenase (Silva et al., 2001). In this study, administration of 250 
mg/kg body weight of tyloxapol induced liver cells degeneration, fibrosis and necrosis which were not found in 
groups pre-fed with the FCV-composed feed. This again suggests that regular intake of the condiment might 
possess hepatoprotective effect. 
In view of the fact that diet and/or drug administration have been identified as a major way of preventing or 
treating many disorders linked with hyperlipidaemia and lipid disorders generally (Marie & Vladim, 2001; 
Grundy et al., 2004), the findings from this study is of extreme importance.  
5. Conclusion  
In conclusion, diets formulated with fermented Citrullus vulgaris seeds have hypolipidaemic activity in 
tyloxapol–induced hyperlipidaemia in rats. The condiment may be useful in lowering cholesterol and 
triglycerides levels in hyperlipidaemia. Further studies in others animal species and in other hyperlipidaemic 
model are required to elucidate its hypolipidaemic activity. Long term toxicity tests at greater concentrations are 
also recommended. However, consumption of fermented Citrullus vulgaris seeds is recommended in humans 
based on the results of this study. 
Abbreviations: 
FCV, fermented Citrullus vulgaris; LDL-C, low density lipoprotein cholesterol; HDL, High density lipoprotein 
cholesterol; TC, Total Cholesterol; TG, Triglycerides; OSF, ogiri-supplemented Feed; DPPH, 2,2-Diphenyl-1- 
picrylhydrazyl; 
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